Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study

BACKGROUND: Despite optimal neoadjuvant chemotherapy only 40% of gastric cancer tumours achieve complete or partial treatment response. In the absence of treatment response, neoadjuvant chemotherapy in gastric cancer contributes to adverse events without additional survival benefit compared to adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Skubleny, Daniel, Lin, Andrea, Garg, Saurabh, McLean, Ross, McCall, Michael, Ghosh, Sunita, Spratlin, Jennifer L, Schiller, Daniel, Rayat, Gina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994053/
https://www.ncbi.nlm.nih.gov/pubmed/36908322
http://dx.doi.org/10.4251/wjgo.v15.i2.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994053/
https://www.ncbi.nlm.nih.gov/pubmed/36908322
http://dx.doi.org/10.4251/wjgo.v15.i2.303

Ejemplares similares